Nanodevices for studying nano-pathophysiology

Advanced Drug Delivery Reviews

Volumn 74, Issue , 2014, Pages 35-52

  Cabral, Horacio ^a   Miyata, Kanjiro ^b   Kishimura, Akihiro ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Nanomaterials; Polymeric self assemblies; Theranostic nano devices

Indexed keywords

HISTOLOGY; LIPOSOMES; MICELLES; MOLECULAR BIOLOGY; NANOSTRUCTURED MATERIALS; THERANOSTICS; TISSUE;

BIOLOGICAL TISSUES; DIAGNOSTIC APPROACH; NANO DEVICE; NANO-SCALED DEVICES; PROGRAMMED OPERATIONS; SPECIFIC DETECTION; SUBCELLULAR TARGETING; THERAPEUTIC AGENTS;

POLYMERS;

GOLD NANOPARTICLE; IRON OXIDE NANOPARTICLE; LIPOSOME; MESOPOROUS SILICA NANOPARTICLE; METAL NANOPARTICLE; POLYMER; QUANTUM DOT; UNCLASSIFIED DRUG; LIGAND; LIPID; MICELLE; NANOMATERIAL; COPOLYMER; MACROGOL; NANOPARTICLE; POLYANION; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

CELL STRUCTURE; DRUG DELIVERY SYSTEM; HUMAN; LIGAND BINDING; MICELLE; NANOANALYSIS; NANODEVICE; NANOTECHNOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; SURFACE PROPERTY; TISSUE STRUCTURE; ANIMAL; CHEMISTRY; DIAGNOSTIC USE; DRUG DESIGN; DRUG RELEASE; ENDOCYTOSIS; HYDROPHILICITY; LIPOSOMAL DELIVERY; NANOENGINEERING; PARTICLE SIZE; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ANIMALS; HUMANS; LIGANDS; LIPIDS; MICELLES; NANOSTRUCTURES; POLYMERS;

EID: 84906066469     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2014.06.003     Document Type: Review

References (244)

1. Allen T.M., Cullis P.R. Drug delivery systems: entering the mainstream. Science 2004, 303:1818-1822.
2. Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2007, 2:751-760.
3. Duncan R. Polymer therapeutics as nanomedicines: new perspectives. Curr. Opin. Biotechnol. 2011, 22:492-501.
4. Kataoka K., Harada A., Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv. Drug Deliv. Rev. 2001, 47:113-131.
5. Matsumura Y., Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS. Cancer Res. 1986, 46:6387-6392.
6. Yuan F., Salehi H.A., Boucher Y., Vasthare U.S., Tuma R.F., Jain R.K. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res. 1994, 54:4564-4568.
7. Kano M.R., Bae Y., Iwata C., Morishita Y., Yashiro M., Oka M., Fujii T., Komuro A., Kiyono K., Kaminishi M., Hirakawa K., Ouchi Y., Nishiyama N., Kataoka K., Miyazono K. Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-signaling. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:3460-3465.
8. Yu H.-D., Regulacio M., Yea E., Han M.-Y. Chemical routes to top-down nanofabrication. Chem. Soc. Rev. 2013, 42:6006-6018.
9. Perry J.L., Herlihy K.P., Napier M.E., DeSimone J.M. PRINT: a novel platform toward shape and size specific nanoparticle theranostics. Acc. Chem. Res. 2011, 44:990-998.
10. Gregoriadis G. The carrier potential of liposomes in biology and medicine. Part 2. N. Engl. J. Med. 1976, 295:765-770.
11. Torchilin V.P. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 2005, 4:145-160.
12. Allen T.M., Cullis P.R. Liposomal drug delivery systems: from concept to clinical applications. Adv. Drug Deliv. Rev. 2013, 65:36-48.
13. Cushing B.L., Kolesnichenko V.L., O'Connor C.J. Recent advances in the liquid-phase syntheses of inorganic nanoparticles. Chem. Rev. 2004, 104:3893-3946.
14. Huang H.-C., Barua S., Sharma G., Dey S.K., Rege K. Inorganic nanoparticles for cancer imaging and therapy. J. Control. Release 2011, 155:344-357.
15. Fadeel B., Garcia-Bennett A.E. Better safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Adv. Drug Deliv. Rev. 2010, 62:362-374.
16. Olson F., Hunt C.A., Szoka F.C., Vail W.J., Papahadjopoulos D. Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. Biochim. Biophys. Acta 1979, 557:9-23.
17. Drummond D.C., Meyer O., Hong K., Kirpotin D.B., Papahadjopoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol. Rev. 1999, 51:691-744.
18. Allen T.M., Everest J.M. Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats. J. Pharmacol. Exp. Ther. 1983, 226:539-544.
19. Ishida T., Harashima H., Kiwada H. Liposome clearance. Biosci. Rep. 2002, 22:197-224.
20. Klibanov A.L., Maruyama K., Torchilin V.P., Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 1990, 268:235-238.
21. Allen C., Dos Santos N., Gallagher R., Chiu G.N., Shu Y., Li W.M., Johnstone S.A., Janoff A.S., Mayer L.D., Webb M.S., Bally M.B. Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol). Biosci. Rep. 2002, 22:225-250.
22. Davis F.F. The origin of PEGnology. Adv. Drug Deliv. Rev. 2002, 54:457-458.
23. Abuchowski A., McCoy J.R., Palczuk N.C., van Es T., Davis F.F. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J. Biol. Chem. 1977, 252:3582-3586.
24. Allen T.M., Hansen C., Rutledge J. Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues. Biochim. Biophys. Acta - Biomembranes 1989, 981:27-35.
25. Scherphof G.L., Kamps J.A.A.M. Receptor versus non-receptor mediated clearance of liposomes. Adv. Drug Deliv. Rev. 1998, 32:81-97.
26. Krown S.E., Northfelt D.W., Osoba D., Stewart J.S. Use of liposomal anthracyclines in Kaposi's sarcoma. Semin. Oncol. 2004, 31:36-52.
27. Rose P.G. Pegylated liposomal doxorubicin: optimizing the dosing schedule in ovarian cancer. Oncologist 2005, 10:205-214.
28. Perez A.T., Domenech G.H., Frankel C., Vogel C.L. Pegylated liposomal doxorubicin (Doxil®) for metastatic breast cancer: the Cancer Research Network, Inc., experience. Cancer Invest. 2002, 20:22-29.
29. Müller R.H., Mäder K., Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur. J. Pharm. Biopharm. 2000, 50:161-177.
30. Wilschut Jan, Hoekstra Dick Membrane fusion: from liposomes to biological membranes. Trends Biochem. Sci. 1984, 9:479-483.
31. Jahn R., Lang T., Südhof T.C. Membrane fusion. Cell 2003, 112:519-533.
32. Jahn R., Scheller R.H. SNAREs-engines for membrane fusion. Nat. Rev. Mol. Cell Biol. 2006, 7:631-643.
33. Youle R.J., Van Der Bliek A.M. Mitochondrial fission, fusion, and stress. Science 2012, 337:1062-1065.
34. Azmi A.S., Bao B., Sarkar F.H. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev. 2013, 32:623-642.
35. Eckert D.M., Kim P.S. Mechanisms of viral membrane fusion and its inhibition. Ann. Rev. Biochem. 2001, 70:777-810.
36. Malinin V.S., Frederik P., Lentz B.R. Osmotic and curvature stress affect PEG-induced fusion of lipid vesicles but not mixing of their lipids. Biophys. J. 2002, 82:2090-2100.
37. Siegel D.P., Banschbach J., Alford D., Ellens H., Lis L.J., Quinn P.J., Yeagle P.L., Bentz J. Physiological levels of diacylglycerols in phospholipid membranes induce membrane fusion and stabilize inverted phases. Biochemistry 1989, 38:3703-3709.
38. Burgess S.W., McIntosh T.J., Lentz B.R. Modulation of poly(ethylene glycol)-induced fusion by membrane hydration: importance of interbilayer separation. Biochemistry 1992, 31:2653-2661.
39. Bailey A.L., Cullis P.R. Membrane fusion with cationic liposomes: effects of target membrane lipid composition. Biochemistry 1997, 36:1628-1634.
40. Akita H., Kudo A., Minoura A., Yamaguti M., Khalil I.A., Moriguchi R., Masuda T., Danev R., Nagayama K., Kogure K., Harashima H. Multi-layered nanoparticles for penetrating the endosome and nuclear membrane via a step-wise membrane fusion process. Biomaterials 2009, 30:2940-2949.
41. Sadzuka Y., Kishi K., Hirota S., Sonobe T. Effect of polyethyleneglycol (PEG) chain on cell uptake of PEG-modified liposomes. J. Liposome Res. 2003, 13:157-172.
42. Straubinger R.M., Düzgünes N., Papahadjopoulos D. pH-sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules. FEBS Lett. 1985, 179:148-154.
43. Sukharev S.I., Blount P., Martinac B., Blattner F.R., Kung C. A large mechanosensitive channel in E. coli encoded by mscL alone. Nature 1994, 368:265-268.
44. Martinac B. Mechanosensitive ion channels: molecules of mechanotransduction. J. Cell Sci. 2004, 117:2449-2460.
45. Holme M.N., Fedotenko I.A., Abegg D., Althaus J., Babel L., Favarger F., Reiter R., Tanasescu R., Zaffalon P.L., Ziegler A., Müller B., Saxer T., Zumbuehl A. Shear-stress sensitive lenticular vesicles for targeted drug delivery. Nat. Nanotechnol. 2012, 7:536-554.
46. Jaalouk D.E., Lammerding J. Mechanotransduction gone awry. Nat. Rev. Mol. Cell Biol. 2009, 10:63-73.
47. Petersen A.L., Hansen A.E., Gabizon A., Andresen T.L. Liposome imaging agents in personalized medicine. Adv. Drug Deliv. Rev. 2012, 64:1417-1435.
48. Harrington K.J., Mohammadtaghi S., Uster P.S., Glass D., Peters A.M., Vile R.G., Stewart J.S.W. Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin. Cancer Res. 2001, 7(2):243-254.
49. Viglianti B.L., Abraham S.A., Michelich C.R., Yarmolenko P.S., MacFall J.R., Bally M.B., Dewhirst M.W. In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: illustration of targeted delivery. Magn. Reson. Med. 2004, 51:1153-1162.
50. Løkling K.E., Fossheim S.L., Skurtveit R., Bjørnerud A., Klaveness J. pH-sensitive paramagnetic liposomes as MRI contrast agents: in vitro feasibility studies. Magn. Reson. Imaging 2001, 19:731-738.
51. Begu S., Mordon S., Desmettre T., Devoisselle J.M. Fluorescence imaging method for in vivo pH monitoring during liposomes uptake in rat liver using a pH-sensitive fluorescent dye. J. Biomed. Opt. 2005, 10:024008.
52. McNamara K.P., Rosenzweig N., Rosenzweig Z. Liposome-based optochemical nanosensors. Microchim. Acta 1999, 131:57-64.
53. Li D., Patel A.R., Klibanov A.L., Kramer C.M., Ruiz M., Kang B.Y., Mehta J.L., Beller G.A., Glover D.K., Meyer C.H. Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance. Circ. Cardiovasc. Imaging 2010, 3:464-472.
54. Ogawa M., Umeda I.O., Kosugi M., Kawai A., Hamaya Y., Takashima M., Yin H., Kudoh T., Seno M., Magata Y. Development of 111In-labeled liposomes for vulnerable atherosclerotic plaque imaging. J. Nucl. Med. 2014, 55:115-120.
55. 64Cu liposomes. Biomaterials 2012, 33:7785-7793.
56. Al-Jamal W., Kostarelos K. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine. Acc. Chem. Res. 2011, 44:1094-1104.
57. Jain R.K., Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat. Rev. Clin. Oncol. 2010, 7:653-664.
58. Mukerjee P. The nature of the association equilibria and hydrophobic bonding in aqueous solutions of association colloids. Adv. Colloid Interf. Sci. 1967, 1:242-275.
59. Klok H.-A., Lecommandoux S. Supramolecular materials via block copolymer self-assembly. Adv. Mater. 2001, 13:1217-1229.
60. Mai Y., Eisenberg A. Self-assembly of block copolymers. Chem. Soc. Rev. 2012, 41:5969-5985.
61. Schacher F.H., Rupar P.A., Manners I. Functional block copolymers: nanostructured materials with emerging applications. Angew. Chem. Int. Ed. 2012, 51:7898-7921.
62. Allen C., Maysinger D., Eisenberg A. Nano-engineering block copolymer aggregates for drug delivery. Colloids Surf. B: Biointerfaces 1999, 16:3-27.
63. Lavasanifar A., Samuel J., Kwon G.S. Poly(ethylene oxide)-b-poly(l-amino acid) micelles for drug delivery. Adv. Drug Deliv. Rev. 2002, 54:169-190.
64. Rösler A., Vandermeulen G.W.M., Klok H.-A. Advanced drug delivery devices via self-assembly of amphiphilic block copolymers. Adv. Drug Deliv. Rev. 2012, 64:270-279.
65. Nishiyama N., Kataoka K. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol. Ther. 2006, 112:630-648.
66. Osada K., Christie R.J., Kataoka K. Polymeric micelles from poly(ethylene glycol)-poly(amino acid) block copolymer for drug and gene delivery. J. R. Soc. Interface 2009, 3:S325-S339.
67. Miyata K., Christie R.J., Kataoka K. Polymeric micelles for nano-scale drug delivery. React. Funct. Polym. 2011, 7:227-234.
68. Cabral H., Nishiyama N., Kataoka K. Supramolecular nanodevices: from design validation to theranostic nanomedicine. Acc. Chem. Res. 2011, 44:999-1008.
69. Kim S.Y., Shin I.G., Lee Y.M., Cho C.S., Sung Y.K. Methoxy poly(ethylene glycol)/ε-caprolactone amphiphilic block copolymeric micelles containing indomethacin. I. Preparation and characterization. J. Control. Release 1998, 51:1-11.
70. Allen C., Yu Y., Maysinger D., Eisenberg A. Polycaprolactone-b-poly(ethylene oxide) block copolymer micelles as a novel drug delivery vehicle for neurotrophic agents FK506 and L-685,818. Bioconjug. Chem. 1998, 9:564-572.
71. Yoo H.S., Park T.G. Biodegradable polymeric micelles composed of doxorubicin conjugate PLGA-PEG block copolymer. J. Control. Release 2001, 70:63-70.
72. Kabanov A.V., Chekhonin V.P., Alakhov V., Batrakova E.V., Lebedev A.S., Melik-Nubarov N.S., Arzhakov S.A., Levashov A.V., Morozov G.V., Severin E.S. The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles. Micelles as microcontainers for drug targeting. FEBS Lett. 1989, 258:343-345.
73. Kabanov A.V., Alakov V.Y. Pluronic block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers. Crit. Rev. Ther. Drug Carrier Syst. 2002, 19:1-73.
74. Hagan S.A., Coombes A.G.A., Garnett M.C., Dunn S.E., Davies M.C., Illum L., Davis S.S., Harding S.E., Purkiss S., Gellert P.R. Polylactide-poly(ethylene glycol) copolymers as drug delivery systems. 1. Characterization of water dispersible micelle-forming systems. Langmuir 1996, 12:2153-2161.
75. Yamamoto Y., Nagasaki Y., Kato M., Kataoka K. Surface charge modulation of poly(ethylene glycol)-poly(d, l-lactide) block copolymer micelles: conjugation of charged peptides. Colloids Surf. B Biointerfaces 1999, 16:135-146.
76. Stolnik S., Heald C.R., Neal J., Garnett M.C., Davis S.S., Illum L., Purkis S.D., Barlow R.J., Gellert P.R. Polylactide-poly(ethylene glycol) micellar-like particles as potential drug carriers: production, colloidal properties, and biological performance. J. Drug Target. 2001, 9:361-378.
77. Liggins R.T., Burt H.M. Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations. Adv. Drug Deliv. Rev. 2002, 54:191-202.
78. Francis M.F., Cristea M., Yang Y., Winnik F.M. Engineering polysaccharide-based polymeric micelles to enhance permeability of cyclosporin A across Caco-2 cells. Pharm. Res. 2005, 22:209-219.
79. Raemdonck K., Martens T.F., Braeckmans K., Demeester J., De Smedt S.C. Polysaccharide-based nucleic acid nanoformulations. Adv. Drug Deliv. Rev. 2013, 65:1123-1147.
80. Yokoyama M., Inoue S., Kataoka K., Yui N., Okano T., Sakurai Y. Molecular design for missile drug: synthesis of adriamycin conjugated with immunoglobulin G using poly(ethylene glycol)-block-poly(aspartic acid) as intermediate carrier. Makromol. Chem. 1989, 190:2041-2054.
81. Yokoyama M., Miyauchi M., Yamada N., Okano T., Sakurai Y., Kataoka K., Inoue S. Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res. 1990, 50:1693-1700.
82. Nakanishi T., Fukushima S., Okamoto K., Suzuki M., Matsumura Y., Yokoyama M., Okano T., Sakurai Y., Kataoka K. Development of the polymer micelle carrier system for doxorubicin. J. Control. Release 2001, 74:295-302.
83. Bader H., Ringsdorf H., Schmidt B. Watersoluble polymers in medicine. Angew. Makromol. Chem. 1984, 123:457-485.
84. Bae Y., Fukushima S., Harada A., Kataoka K. Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change. Angew. Chem. Int. Ed. 2003, 42:4640-4643.
85. Nishiyama N., Kataoka K. Preparation and characterization of size-controlled polymeric micelle containing cis-dichlorodiammineplatinum(II) in the core. J. Control. Release 2001, 74:83-94.
86. Nishiyama N., Okazaki S., Cabral H., Miyamoto M., Kato Y., Sugiyama Y., Nishio K., Matsumura Y., Kataoka K. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res. 2003, 63:8977-8983.
87. Cabral H., Nishiyama N., Okazaki S., Koyama H., Kataoka K. Preparation and biological properties of dichloro(1,2-diaminocyclohexane) platinum(II)(DACHPt)-loaded polymeric micelles. J. Control. Release 2005, 101:223-232.
88. Cabral H., Nishiyama N., Kataoka K. Optimization of (1,2-diamino-cyclohexane)platinum(II)-loaded polymeric micelles directed to improved tumor targeting and enhanced antitumor activity. J. Control. Release 2007, 121:146-155.
89. Cabral H., Murakami M., Hojo H., Terada Y., Kano M.R., Chung U., Nishiyama N., Kataoka K. Targeted therapy of spontaneous murine pancreatic and prevents peritoneal metastasis. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:11397-11402.
90. Matsumura Y., Kataoka K. Preclinical and clinical studies of anticancer agent-incorporating polymer micelles. Cancer Sci. 2009, 100:572-579.
91. Plummer R., Wilson R.H., Calvert H., Boddy A.V., Griffin M., Sludden J., Tilby M.J., Eatock M., Pearson D.G., Ottley C.J., Matsumura Y., Kataoka K., Nishiya T. A phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours. Br. J. Cancer 2011, 104:593-598.
92. Kato K., Chin K., Yoshikawa T., Yamaguchi K., Tsuji Y., Esaki T., Sakai K., Kimura M., Hamaguchi T., Shimada Y., Matsumura Y., Ikeda R. Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer. Invest. New Drugs 2012, 30:1621-1627.
93. Matsumura Y. Preclinical and clinical studies of NK012, an SN-38-incorporating polymeric micelles, which is designed based on EPR effect. Adv. Drug Deliv. Rev. 2011, 63:184-192.
94. Hamaguchi T., Kato K., Yasui H., Morizane C., Ikeda M., Ueno H., Muro K., Yamada Y., Okusaka T., Shirao K., Shimada Y., Nakahama H., Matsumura Y. A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation. Br. J. Cancer 2007, 97:170-176.
95. Matsumura Y., Hamaguchi T., Ura T., Muro K., Yamada Y., Shimada Y., Shirao K., Okusaka T. Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br. J. Cancer 2004, 91:1775-1781.
96. Kataoka K., Togawa H., Harada A., Yasugi K., Matsumoto T., Katayose S. Spontaneous formation of polyion complex micelles with narrow distribution from antisense oligonucleotide and cationic block copolymer in physiological saline. Macromolecules 1996, 29:8556-8557.
97. Kakizawa Y., Kataoka K. Block copolymer micelles for delivery of gene and related compounds 2002, 54:203-222.
98. Miyata K., Nishiyama N., Kataoka K. Rational design of smart supramolecular assemblies for gene delivery: chemical challenges in the creation of artificial viruses. Chem. Soc. Rev. 2012, 41:2562-2574.
99. Uchida S., Itaka K., Uchida H., Hayakawa S., Ogata T., Ishii T., Fukushima S., Osada K., Kataoka K. In vivo messenger RNA introduction into the central nervous system using polyplex nanomicelle. PLoS One 2013, 8:e56220.
100. Wattiau R., Laurent N., Wattiaux-De Coninck S., Jadot M. Endosomes, lysosomes: their implication in gene transfer. Adv. Drug Deliv. Rev. 2000, 41:201-208.
101. Boussif O., Lezoualćh F., Zanta M.A., Mergny M.D., Scherman D., Kemeneix B., Behr J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:7297-7301.
102. Neu M., Fischer D., Kissel T. Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives. J. Gene Med. 2005, 7:992-1009.
103. Hunter A.C. Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity. Adv. Drug Deliv. Rev. 2006, 58:1523-1531.
104. Moghimi S.M., Symonds P., Murray J.C., Hunter A.C., Debska G., Szewczyk A. A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. Mol. Ther. 2005, 11:990-995.
105. Liu Y., Wenning L., Lynch M., Reineke T.M. New poly(d-glucaramidoamine)s induce DNA nanoparticle formation and efficient gene delivery into mammalian cells. J. Am. Chem. Soc. 2004, 126:7422-7423.
106. Lin C., Blaauboer C.J., Timoneda M.M., Lok M.C., van Steenbergen M., Hennink W.E., Zhong Z.Y., Feijen J., Engbersen J.F.J. Bioreducible poly(amido amine)s with oligoamine side chains: synthesis, characterization, and structural effects on gene delivery. J. Control. Release 2008, 126:166-174.
107. Masago K., Itaka K., Nishiyama N., Chung U.-I., Kataoka K. Gene delivery with biocompatible cationic polymer: pharmacogenomic analysis on cell bioactivity. Biomaterials 2007, 28:5169-5175.
108. Miyata K., Oba M., Nakanishi M., Fukushima S., Yamasaki Y., Koyama H., Nishiyama N., Kataoka K. Polyplexes from poly(aspartamide) bearing 1,2-diaminoethane side chains induce pH-selective, endosomal membrane destabilization with amplified transfection and negligible cytotoxicity. J. Am. Chem. Soc. 2008, 130:16287-16294.
109. Uchida H., Miyata K., Oba M., Ishii T., Suma T., Itaka K., Nishiyama N., Kataoka K. Odd-even effect of repeating aminoethylene units in the side chain of N-substituted polyaspartamides on gene transfection profiles. J. Am. Chem. Soc. 2011, 133:15524-15532.
110. Nakanishi M., Park J.-S., Jang W.-D., Oba M., Kataoka K. Study of the quantitative aminolysis reaction of poly(β-benzyl l-aspartate) (PBLA) as a platform polymer for functionality materials. React. Funct. Polym. 2007, 67:1361.
111. Itaka K., Kanayama N., Nishiyama N., Jang W.-D., Yamasaki Y., Nakamura K., Kawaguchi H., Kataoka K. Supramolecular nanocarrier of siRNA from PEG-based block catiomer carrying diamine side chain with distinctive pKa directed to enhance intracellular gene silencing. J. Am. Chem. Soc. 2004, 126:13612-13613.
112. Kanayama N., Fukushima S., Nishiyama N., Itaka K., Jang W.-D., Miyata K., Yamasaki Y., Chung U., Kataoka K. A PEG-based biocompatible block catiomer with high buffering capacity for the construction of polyplex micelles showing efficient gene transfer toward primary cells. ChemMedChem 2006, 1:439.
113. Miyata K., Fukushima S., Nishiyama N., Yamasaki Y., Kataoka K. PEG-based block catiomers possessing DNA anchoring and endosomal escaping functions to form polyplex micelles with improved stability and high transfection efficacy. J. Control. Release 2007, 122:252-260.
114. Akagi D., Oba M., Koyama H., Nishiyama N., Fukushima S., Miyata T., Nagawa H., Kataoka K. Biocompatible micellar nanovectors achieve efficient gene transfer to vascular lesions without cytotoxicity and thrombus formation. Gene Ther. 2007, 14:1029-1038.
115. Suma T., Miyata K., Ishii T., Uchida S., Uchida H., Itaka K., Nishiyama N., Kataoka K. Enhanced stability and gene silencing ability of siRNA-loaded polyion complexes formulated from polyaspartamide derivatives with a repetitive array of amino groups in the side chain. Biomaterials 2012, 33:2770-2779.
116. Kakizawa Y., Miyata K., Furukawa S., Kataoka K. Size-controlled formation of a calcium phosphate-based organic-inorganic hybrid vector for gene delivery using poly(ethylene glycol)-block-poly(aspartic acid). Adv. Mater. 2004, 16:699-702.
117. Kakizawa Y., Furukawa S., Ishii A., Kataoka K. Organic-inorganic hybrid-nanocarrier of siRNA constructing through the self-assembly of calcium phosphate and PEG-based block aniomer. J. Control. Release 2006, 111:368-370.
118. Pittella F., Miyata K., Maeda Y., Suma T., Watanabe S., Chen Q., Christie R.J., Osada K., Nishiyama N., Kataoka K. Pancreatic cancer therapy by systemic administration of VEGF siRNA contained in calcium phosphate/charge-conversional polymer hybrid nanoparticles. J. Control. Release 2012, 161:868-874.
119. Han M., Oba M., Nishiyama N., Kano M.R., Kizaka-Kondoh S., Kataoka K. Enhanced percolation and gene expression in tumor hypoxia by PEGylated polyplex micelles. Mol. Ther. 2009, 17:1404-1410.
120. Yuan F., Salehi H.A., Boucher Y., Vasthare U.S., Tuma R.F., Jain R.K. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res. 1994, 54:4564-4568.
121. Netti P.A., Berk D.A., Swartz M.A., Grodzinsky A.J., Jain R.K. Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res. 2000, 60:2497-2503.
122. Zhang L., Nishihara H., Kano M.R. Pericyte-coverage of human tumor vasculature and nanoparticle permeability. Biol. Pharm. Bull. 2012, 35:761-766.
123. Jain R.K., Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat. Rev. Clin. Oncol. 2010, 7:653-664.
124. Cabral H., Matsumoto Y., Mizuno K., Chen Q., Murakami M., Kimura M., Terada Y., Kano M.R., Miyazono K., Uesaka M., Nishiyama N., Kataoka K. Accumulation of sub-100nm polymeric micelles in poorly permeable tumours depends on size. Nat. Nanotechnol. 2011, 6:815-823.
125. Gan Z., Jim T.F., Li M., Yuer Z., Wan S., Wu C. Enzymatic biodegradation of poly(ethylene oxide-b-ε-caprolactone) diblock copolymer and its potential biomedical applications. Macromolecules 1999, 32:590-594.
126. Katayama Y., Sonoda T., Maeda M. A polymer micelle responding to the protein kinase A signal. Macromolecules 2001, 34:8569-8573.
127. Lee E.S., Shin H.J., Na K., Bae Y.H. Poly(l-histidine)-PEG block copolymer micelles and pH-induced destabilization. J. Control. Release 2003, 90:363-374.
128. Lee Y., Ishii T., Cabral H., Kim H.-J., Seo J.-H., Nishiyama N., Oshima H., Osada K., Kataoka K. Charge-conversional polyionic complex micelles-efficient nanocarriers for protein delivery into cytoplasm. Angew. Chem. Int. Ed. Engl. 2009, 48:5309-5312.
129. Ren H., Wu Y., Ma N., Xu H., Zhang X. Side-chain selenium-containing amphiphilic block copolymers: redox-controlled self-assembly and disassembly. Soft Matter 2012, 8:1460-1466.
130. Gupta M.K., Meyer T.A., Nelson C.E., Duvall C.L. Poly(PS-b-DMA) micelles for reactive oxygen species triggered drug release. J. Control. Release 2012, 162:591-598.
131. Ma N., Li Y., Xu H., Wang Z., Zhang X. Dual redox responsive assemblies formed from diselenide block copolymers. J. Am. Chem. Soc. 2010, 132:442-443.
132. Kakizawa Y., Harada A., Kataoka K. Environment-sensitive stabilization of core-shell structured polyion complex micelle by reversible cross-linking of the core through disulfide bond. J. Am. Chem. Soc. 1999, 121:11247-11248.
133. Miyata K., Kakizawa Y., Nishiyama N., Harada A., Yamasaki Y., Koyama H., Kataoka K. Block catiomer polyplexes with regulated densities of charge and disulfide cross-linking directed to enhance gene expression. J. Am. Chem. Soc. 2004, 126:2355-2361.
134. Matsumoto S., Christie R.J., Nishiyama N., Miyata K., Ishii A., Oba M., Koyama H., Yamasaki Y., Kataoka K. Environment-responsive block copolymer micelles with a disulfide cross-linked core for enhanced siRNA delivery. Biomacromolecules 2009, 10:119-127.
135. Miyata K., Kakizawa Y., Nishiyama N., Yamasaki Y., Watanabe T., Kohara M., Kataoka K. Freeze-dried formulations for in vivo gene delivery of PEGylated polyplex micelles with disulfide crosslinked cores to the liver. J. Control. Release 2004, 109:15-23.
136. 2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat. Med. 1997, 3:177-182.
137. Maxfield F.R., Yamashiro D.J. Endosome acidification and the pathways of receptor-mediated endocytosis. Adv. Exp. Med. Biol. 1987, 225:189-198.
138. Nathan C., Cunningham-Bussel A. Beyond oxidative stress: an immunologist's guide to reactive oxygen species. Nat. Rev. Immunol. 2013, 13:349-361.
139. Davies K.J.A. Protein damage and degradation by oxygen radicals. I. General aspects. J. Biol. Chem. 1987, 262:9895-9901.
140. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
141. Trubetskoy V.S., Gazelle G.S., Wolf G.L., Torchilin V.P. Block-copolymer of polyethylene glycol and polylysine as a carrier of organic iodine: design of long-circulating particulate contrast medium for X-ray computed tomography. J. Drug Target. 1997, 4:381-388.
142. Rapoport N., Gao Z., Kennedy A. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J. Natl. Cancer Inst. 2007, 99:1095-1106.
143. Kaida S., Cabral H., Kumagai M., Kishimura A., Terada Y., Sekino M., Aoki I., Nishiyama N., Tani T., Kataoka K. Visible drug delivery by supramolecular nanocarriers directing to single-platformed diagnosis and therapy of pancreatic tumor model. Cancer Res. 2010, 70:7031-7041.
144. Nasongkla N., Bey E., Ren J., Ai H., Khemtong C., Guthi J.S., Chin S.-F., Sherry A.D., Boothman D.A., Gao J. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett. 2006, 6:2427-2430.
145. Lee H., Lee E., Kim D., Jang N., Jeong Y., Jon S. Antibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging. J. Am. Chem. Soc. 2006, 128:7383-7389.
146. Yu M., Jeong Y., Park J., Park S., Kim J., Min J., Kim K., Jon S. Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo. Angew. Chem. Int. Ed. 2008, 47:5362-5365.
147. Maldonado C.R., Gómez-Blanco N., Jauregui-Osoro M., Brunton V.G., Yate L., Mareque-Rivas J.C. QD-filled micelles which combine SPECT and optical imaging with light-induced activation of a platinum(IV) prodrug for anticancer applications. Chem. Commun. 2013, 49:3985-3987.
148. Xiao Y., Hong H., Javadi A., Engle J.W., Xu W., Yang Y., Zhang Y., Barnhart T.E., Cai W., Gong S. Multifunctional unimolecular micelles for cancer-targeted drug delivery and positron emission tomography imaging. Biomaterials 2012, 33:3071-3082.
149. Zhang I., Eisenberg A. Multiple morphologies of "crew-cut" aggregates of polystyrene-b-poly(acrylicacid) blockcopolymers. Science 1995, 268:1728-1731.
150. Blanazs A., Armes S.P., Ryan A.J. Self-assembled block copolymer aggregates: from micelles to vesicles and their biological applications. Macromol. Rapid Commun. 2009, 30:267-277.
151. Meng F., Zhong Z., Feijen J. Stimuli-responsive polymersomes for programmed drug delivery. Biomacromolecules 2009, 10:197-209.
152. Li M.-H., Keller P. Stimuli-responsive polymer vesicles. Soft Matter 2009, 5:927-937.
153. Lee J.S., Feijen J. Polymersomes for drug delivery: design, formation and characterization. J. Control. Release 2012, 161:473-483.
154. Najer A., Wu D., Vasquez D., Palivan C.G. Polymer nanocompartments in broad-spectrum medical applications. Nanomedicine 2013, 8:425-447.
155. Aranda-Espinoza H., Bermudez H., Bates F.S., Discher D.E. Electrochemical limits of polymersomes. Phys. Rev. Lett. 2001, 87:208301.
156. Bermudez H., Brannan A.K., Hammer D.A., Bates F.S., Discher D.E. Molecular weight dependence of polymersome membrane structure, elasticity, and stability. Macromolecules 2002, 35:8203-8208.
157. Kishimura A. Development of polyion complex vesicles (PICsomes) from block copolymers for biomedical applications. Polym. J. 2013, 45:892-897.
158. Dong W.-F., Kishimura A., Anraku Y., Chuanoi S., Yamasaki Y., Kataoka K. Monodispersed polymeric nanocapsules: spontaneous evolution and morphology transition from reducible hetero-PEG PICmicelles by controlled degradation. J. Am. Chem. Soc. 2009, 131:3804-3805.
159. Anraku Y., Kishimura A., Oba M., Yamasaki Y., Kataoka K. Spontaneous formation of nanosized unilamellar polyion complex vesicles with tunable size and properties. J. Am. Chem. Soc. 2010, 132:1631-1636.
160. Chuanoi S., Dong W.-F., Kishimura A., Anraku Y., Kataoka K. Structural factors directing to nanosized polyion complex vesicles (Nano-PICsomes) from a pair of block aniomer/homo catiomer: studies on aniomer segment length and catiomer side chain structure. Polym. J. 2014, 46:130-135.
161. Ahmed F., Pakunlu R.I., Brannan A., Bates F., Minko T., Discher D.E. Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug. J. Control. Release 2006, 116:150-158.
162. Feang A., Yuan J. Smart nanocontainers: progress on novel stimuli-responsive polymer vesicles. Macromol. Rapid Commun. 2014, 35:767-779.
163. Rodríguez-Hernández J., Lecommandoux S. Reversible inside-out micellization of pH-responsive and water-soluble vesicles based on polypeptide diblock copolymers. J. Am. Chem. Soc. 2005, 127:2026-2027.
164. Bellomo E.G., Wyrsta M.D., Pakstis L., Pochan D.J., Deming T.J. Stimuli-responsive polypeptide vesicles by conformation-specific assembly. Nat. Mater. 2004, 3:244-248.
165. Kishimura A., Liamsuwan S., Matsuda H., Dong W.-F., Osada K., Yamasakia Y., Kataoka K. pH-dependent permeability change and reversible structural transition of PEGylated polyion complex vesicles (PICsomes) in aqueous media. Soft Matter 2009, 5:529-532.
166. Napoli A., Valentini M., Tirelli N., Müller M., Hubbell J.A. Oxidation-responsive polymeric vesicles. Nat. Mater. 2004, 3:183-189.
167. Napoli A., Boerakker M.J., Tirelli N., Nolte R.J.M., Sommerdijk N.A.J.M., Hubbell J.A. Glucose-oxidase based self-destructing polymeric vesicles. Langmuir 2004, 20:3487-3491.
168. Scott E.A., Stano A., Gillar M., Maio-Liu A.C., Swartz M.A., Hubbell J.A. Dendritic cell activation and T cell priming with adjuvant- and antigen-loaded oxidation-sensitive polymersomes. Biomaterials 2012, 33:6211-6219.
169. Vasdekis A.E., Scott E.A., O'Neil C.P., Psaltis D., Hubbell J.A. Precision intracellular delivery based on optofluidic polymersome rupture. ACS Nano 2012, 6:7850-7857.
170. Spulber M., Najer A., Winkelbach K., Glaied O., Waser M., Pieles U., Meier W., Bruns N. Photoreaction of a hydroxyalkyphenone with the membrane of polymersomes: a versatile method to generate semipermeable nanoreactors. J. Am. Chem. Soc. 2013, 135:9204-9212.
171. Wang X., Liu G., Hu J., Zhang G., Liu S. Concurrent block copolymer polymersome stabilization and bilayer permeabilization by stimuli-regulated "traceless" crosslinking. Angew. Chem. Int. Ed. 2014, 53:3138-3142.
172. Kita-Tokarczyk K., Grumelard J., Haefele T., Meijer W. Block copolymer vesicles - using concepts from polymer chemistry to mimic biomembranes. Polymer 2005, 46:3540-3563.
173. Ranquin A., Versées W., Meier W., Steyaert J., Van Gelder P. Therapeutic nanoreactors: combining chemistry and biology in a novel triblock copolymer drug delivery system. Nano Lett. 2005, 5:2220-2224.
174. Broz P., Driamov S., Ziegler J., Ben-Haim N., Marsch S., Meier W., Hunziker P. Toward intelligent nanosize bioreactors: a pH-switchable, channel-equipped, functional polymer nanocontainer. Nano Lett. 2006, 6:2349-2353.
175. Koide A., Kishimura A., Osada K., Jang W.-D., Yamasaki Y., Kataoka K. Semipermeable polymer vesicle (PICsome) self-assembled in aqueous medium from a pair of oppositely charged block copolymers: physiologically stable micro-/nanocontainers of water-soluble macromolecules. J. Am. Chem. Soc. 2006, 128:5988-5989.
176. Kishimura A., Koide A., Osada K., Yamasaki Y., Kataoka K. Encapsulation of myoglobin in PEGylated polyion complex vesicles made from a pair of oppositely charged block ionomers: a physiologically available oxygen carrier. Angew. Chem. Int. Ed. 2007, 46:6085-6088.
177. Anraku Y., Kishimura A., Kobayashi A., Oba M., Kataoka K. Size-controlled long-circulating PICsome as a ruler to measure critical cut-off disposition size into normal and tumor tissues. Chem. Commun. 2011, 47:6054-6056.
178. Kokuryo D., Anraku Y., Kishimura A., Tanaka S., Kano M.R., Kershaw J., Nishiyama N., Saga T., Aoki I., Kataoka K. SPIO-PICsome: development of a highly sensitive and stealth-capable MRI nano-agent for tumor detection using SPIO-loaded unilamellar polyion complex vesicles (PICsomes). J. Control. Release 2013, 169:220-227.
179. Tomalia D.A., Naylor A.M., Goddard W.A. Starburst dendrimers: molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew. Chem. Int. Ed. 1990, 29:138-175.
180. Daniel M.-C., Astruc D. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem. Rev. 2004, 104:293-346.
181. Laurent S., Forge D., Port M., Roch A., Robic C., Vander Elst L., Muller R.N. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev. 2008, 108:2064-2110.
182. Slowing I.I., Vivero-Escoto J.L., Wu C.-W., Lin V.S.-Y. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv. Drug Deliv. Rev. 2008, 60:1278-1288.
183. Leutwyler W.K., Bürgi S.L., Burgl H.B. Semiconductor clusters, nanocrystals, and quantum dots. Science 1996, 271:933-937.
184. Qian X., Peng X.-H., Ansari D.O., Yin-Goen Q., Chen G.Z., Shin D.M., Yang L., Young A.N., Wang M.D., Nie S. In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat. Biotechnol. 2008, 26:83-90.
185. Dykman L., Khlebtsov N. Gold nanoparticles in biomedical applications: recent advances and perspectives. Chem. Soc. Rev. 2012, 41:2256-2282.
186. Lee S.E., Liu G.L., Kim F., Lee L.P. Remote optical switch for localized and selective control of gene interference. Nano Lett. 2009, 9:562-570.
187. Chithrani B.D., Ghazani A.A., Chan W.C.W. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 2006, 6:662-668.
188. Jiang W., Kim B.Y.S., Rutka J.T., Chan W.C.W. Nanoparticle-mediated cellular response is size-dependent. Nat. Nanotechnol. 2008, 3:145-150.
189. Perrault S.D., Walkey C., Jennings T., Fischer H.C., Chan W.C. Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett. 2009, 9:1909-1915.
190. Arnida M.M., Janát-Amsbury A., Ray C.M., Peterson H. Ghandehari, geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. Eur. J. Pharm. Biopharm. 2011, 77:417-423.
191. Gao J., Gu H., Xu B. Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications. Acc. Chem. Res. 2009, 42:1097-1107.
192. Mahmoudi M., Sant S., Wang B., Laurent S., Sen T. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. Adv. Drug Deliv. Rev. 2011, 63:24-46.
193. Gaster R.S., Hall D.A., Nielsen C.H., Osterfeld S.J., Yu H., Mach K.E., Wilson R.J., Murmann B., Liao J.C., Gambhir S.S., Wang S.X. Matrix-insensitive protein assays push the limits of biosensors in medicine. Nat. Med. 2009, 15:1327-1332.
194. Fu A., Hu W., Xu L., Wilson R.J., Yu H., Osterfeld S.J., Gambhir S.S., Wang S.X. Protein-functionalized synthetic antiferromagnetic nanoparticles for biomolecule detection and magnetic manipulation. Angew. Chem. Int. Ed. 2009, 48:1620-1624.
195. Miller M.C., Doyle G.V., Terstappen L.W.M.M. Significance of circulating tumor cells detected by the cell search system in patients with metastatic breast colorectal and prostate cancer. J. Oncol. 2010, 2010:617421.
196. Stanley S.A., Gagner J.E., Damanpour S., Yoshida M., Dordick J.S., Friedman J.M. Radio-wave heating of iron oxide nanoparticles can regulate plasma glucose in mice. Science 2012, 336:604-608.
197. Souza G.R., Molina J.R., Raphael R.M., Ozawa M.G., Stark D.J., Levin C.S., Bronk L.F., Ananta J.S., Mandelin J., Georgescu M.-M., Bankson J.A., Gelovani J.G., Killian T.C., Arap W., Pasqualini R. Three-dimensional tissue culture based on magnetic cell levitation. Nat. Nanotechnol. 2010, 5:291-296.
198. Alexiou C., Arnold W., Klein R.J., Parak F.G., Hulin P., Bergemann C., Erhardt W., Wagenpfeil S., Luebbe A.S. Locoregional cancer treatment with magnetic drug targeting. Cancer Res. 2000, 60:6641-6664.
199. He Q., Zhang Z., Gao F., Li Y., Shi J. In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation. Small 2011, 7:271-280.
200. Huang X., Li L., Liu T., Hao N., Liu H., Chen D., Tang F. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. ACS Nano 2011, 5:5390-5399.
201. Meng H., Xue M., Xia T., Ji Z., Tarn D.Y., Zink J.I., Nel A.E. Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of DOXorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. ACS Nano 2011, 5:4131-4144.
202. Lu J., Liong M., Li Z., Zink J.I., Tamanoi F. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 2010, 6:1794-1805.
203. Xia T.A., Kovochich M., Liong M., Meng H., Kabehie S., George S., Zink J.I., Nel A.E. Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. ACS Nano 2009, 3:3273-3286.
204. Meng H., Mai W.X., Zhang H., Xue M., Xia T., Lin S., Wang X., Zhao Y., Ji Z., Zink J.I., Nel A.E. Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo. ACS Nano 2013, 7:994-1005.
205. Hirai T., Okubo H., Komasawa I. Size-selective incorporation of CdS nanoparticles into mesoporous silica. J. Phys. Chem. B 1999, 103:4228-4230.
206. Michalet X., Pinaud F.F., Bentolila L.A., Tsay J.M., Doose S., Li J.J., Sundaresan G., Wu A.M., Gambhir S.S., Weiss S. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005, 307:538-544.
207. Mattoussi H., Palui G., Na H.B. Luminescent quantum dots as platforms for probing in vitro and in vivo biological processes. Adv. Drug Deliv. Rev. 2012, 64:138-166.
208. Choi H.S., Liu W., Misra P., Tanaka E., Zimmer J.P., Ipe B.I., Bawendi M.G., Frangioni J.V. Renal clearance of quantum dots. Nat. Biotechnol. 2007, 25:1165-1170.
209. Xing Y., Chaudry Q., Shen C., Kong K.Y., Zhau H.E., Chung L.W., Petros J.A., O'Regan R.M., Yezhelyev M.V., Simons J.W., Wang M.D., Nie S. Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry. Nat. Protoc. 2007, 2:1152-1165.
210. Dahan M., Levi S., Luccardini C., Rostaing P., Riveau B., Triller A. Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking. Science 2003, 302:442-445.
211. Kim S., Lim Y.T., Soltesz E.G., De Grand A.M., Lee J., Nakayama A., Anthony Parker J., Mihaljevic T., Laurence R.G., Dor D.M., Cohn L.H., Bawendi M.G., Frangioni J.V. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat. Biotechnol. 2004, 22:93-97.
212. Al-Jamal W.T., Al-Jamal K.T., Bomans P.H., Frederik P.M., Kostarelos K. Functionalized-quantum-dot-liposome hybrids as multimodal nanoparticles for cancer. Small 2008, 4:1406-1415.
213. Gao X., Cui Y., Levenson R.M., Chung L.W.K., Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 2004, 22:969-976.
214. Ballou B., Lagerholm B.C., Ernst L.A., Bruchez M.P., Waggoner A.S. Noninvasive imaging of quantum dots in mice. Bioconjug. Chem. 2004, 15:79-86.
215. Li L., Daou T.J., Texier I., Chi T.T.K., Liem N.Q., Reiss P. Highly luminescent CuInS2/ZnS core/shell nanocrystals: cadmium-free quantum dots for in vivo imaging. Chem. Mater. 2009, 21:2422-2429.
216. Ow H., Larson D.R., Srivastava M., Baird B.A., Webb W.W., Wiesner U. Bright and stable core-shell fluorescent silica nanoparticles. Nano Lett. 2005, 5:113-117.
217. Benezra M., Penate-Medina O., Zanzonico P.B., Schaer D., Ow H., Burns A., DeStanchina E., Longo V., Herz E., Iyer S., Wolchok J., Larson S.M., Wiesner U., Bradbury M.S. Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. J. Clin. Invest. 2011, 121:2768-2780.
218. Allen T.M. Ligand-targeted therapeutics in anticancer therapy. Nat. Rev. Cancer 2002, 2:750-763.
219. Torchilin V.P., Lukyanov A.N., Gao Z., Papahadjopoulos-Sternberg B. Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:6039-6044.
220. Jin C., Qian N., Zhao W., Yang W., Bai L., Wu H., Wang M., Song W., Dou K. Improved therapeutic effect of DOX-PLGA-PEG micelles decorated with bivalent fragment HAb18 F(ab')(2) for hepatocellular carcinoma. Biomacromolecules 2010, 11:2422-2431.
221. Farokhzad O.C., Cheng J., Teply B.A., Sherifi I., Jon S., Kantoff P.W., Richie J.P., Langer R. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:6315.
222. Ruoslahti E., Bhatia S.N., Sailor M.J. Targeting of drugs and nanoparticles to tumors. J. Cell Biol. 2010, 188:759-768.
223. Bae Y., Jang W.-D., Nishiyama N., Fukushima S., Kataoka K. Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery. Mol. Biosyst. 2005, 1:242-250.
224. Deshayes S., Cabral H., Ishii T., Miura Y., Kobayashi S., Matsumoto A., Miyahara Y., Nishiyama N., Kataoka K. Phenylboronic acid-installed polymeric micelles for targeting sialylated epitopes in solid tumors. J. Am. Chem. Soc. 2013, 135:15501-15507.
225. Asioli S., Maletta F., Verdun di Cantogno L., Satolli M.A., Schena M., Pecchioni C., Botta C., Chiusa L., Molinaro L., Conti L., Viale G., Ingravallo G., Maiorano E., Sapino A. Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer. Hum. Pathol. 2012, 43:2070-2079.
226. Seol H., Lee H.J., Choi Y., Lee H.E., Kim Y.J., Kim J.H., Kang E., Kim SW S.W., Park S.Y. Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance. Mod. Pathol. 2012, 25:938-948.
227. Campbell I.G., Jones T.A., Foulkes W.D., Trowsdale J. Folate-binding protein is a marker for ovarian cancer. Cancer Res. 1991, 51:5329-5338.
228. Weitman S.D., Lark R.H., Coney L.R., Fort D.W., Frasca V., Zurawski V.R., Kamen B.A. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res. 1992, 52:3396-3401.
229. Dube D.H., Bertozzi C.R. Glycans in cancer and inflammation-potential for therapeutics and diagnostics. Nat. Rev. Drug Discov. 2005, 4:477-488.
230. Kannagi R., Izawa M., Koike T., Miyazaki K., Kimura N. Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci. 2004, 95:377-384.
231. Yancopoulos G.D., Klagsbrun M., Folkman J. Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border. Cell 1998, 93:661-664.
232. Brooks P.C., Montgomery A.M.P., Rosenfeld M., Reisfeld R.A., Hu T., Klie G., Cheresh D.A. Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994, 7:1157-1164.
233. Ruoslahti E. RGD and other recognition sequences for integrins. Annu. Rev. Cell Dev. Biol. 1996, 12:697-715.
234. Danhier F., Le Breton A., Préat V. RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis. Mol. Pharm. 2012, 9:2961-2973.
235. Zhan C., Gu B., Xie C., Li J., Liu Y., Lu W. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. J. Control. Release 2010, 143:136-142.
236. Miura Y., Takenaka T., Toh K., Wu S., Nishihara H., Kano M.R., Ino Y., Nomoto T., Matsumoto Y., Koyama H., Cabral H., Nishiyama N., Kataoka K. cRGD-linked polymeric micelles for targeted delivery of platinum anticancer drug to glioblastoma through the blood-brain tumor barrier. ACS Nano 2013, 7:8583-8592.
237. Kim W.J., Yockman J.W., Jeong J.H., Christensen L.V., Lee M., Kim Y.H., Kim S.W. Anti-angiogenic inhibition of tumor growth by systemic delivery of PEI-g-PEG-RGD/pCMV-sFlt-1 complexes in tumor-bearing mice. J. Control. Release 2006, 114:381-388.
238. Oba M., Vachutinsky Y., Miyata K., Kano M.R., Ikeda S., Nishiyama N., Itaka K., Miyazono K., Koyama H., Kataoka K. Antiangiogenic gene therapy of solid tumor by systemic injection of polyplex micelles loading plasmid DNA encoding soluble flt-1. Mol. Pharm. 2010, 7:501-509.
239. Oba M., Aoyagi K., Miyata K., Matsumoto Y., Itaka K., Nishiyama N., Yamasaki Y., Koyama H., Kataoka K. Polyplex micelles with cyclic RGD peptide ligands and disulfide cross-links directing to the enhanced transfection via controlled intracellular trafficking. Mol. Pharm. 2008, 5:1080-1092.
240. Montet X., Funovics M., Montet-Abou K., Weissleder R., Josephson L. Multivalent effects of RGD peptides obtained by nanoparticle display. J. Med. Chem. 2006, 49:6087-6093.
241. Hong S., Leroueil P.R., Majoros I.J., Orr B.G., Baker J.R., Banaszak Holl M.M. The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform. Chem. Biol. 2007, 14:107-115.
242. Torchilin V.P. Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery. Biopolymers 2008, 90:604-610.
243. Rangel R., Guzman-Rojas L., le Roux L.G., Staquicini F.I., Hosoya H., Barbu E.M., Ozawa M.G., Nie J., Dunner K., Langley R.R., Sage E.H., Koivunen E., Gelovani J.R., Lobb R.R., Sidman R.L., Pasqualini R., Arap W. Combinatorial targeting and discovery of ligand-receptors in organelles of mammalian cells. Nat. Commun. 2012, 3:788.
244. Wiley D.T., Webster P., Gale A., Davis M. Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:8662-8667.